首页> 外文期刊>The journal of immunology >Early Presence of Regulatory Cells in Transplanted Rats Rendered Tolerant by Donor-Specific Blood Transfusion
【24h】

Early Presence of Regulatory Cells in Transplanted Rats Rendered Tolerant by Donor-Specific Blood Transfusion

机译:供体特异性输血耐受的移植大鼠中调控细胞的早期存在

获取原文
获取外文期刊封面目录资料

摘要

Mechanisms by which donor-specific blood transfusion (DSBT) promotes organ allograft acceptance are unclear. In a rat fully mismatched cardiac allograft model, we found that DSBT alone (without immunotherapy) induces the development of regulatory T cells (DSBT-Tregs) posttransplant, thereby shedding new light in the mechanisms of the transfusion effect. Compartments and timing of expansion, requirements, and phenotype of DSBT-Tregs are unknown. It is generally assumed that some time is necessary before Tregs develop. However, we show—by adoptive transfer from DSBT—tolerant into naive recipients: 1) the presence of DSBT-Tregs at 5 days posttransplant in spleen and lymph nodes; 2) their gradual expansion in these compartments; and 3) their presence in the graft 14 of 30 days posttransplant. DSBT-Tregs are donor specific and do not protect third-party allografts. Splenocytes from DSBT-treated nontransplanted recipients or from transplanted DSBT-untreated (rejecting) recipients do not transfer tolerance, indicating that both DSBT and graft are required for sufficient numbers of DSBT-Tregs to develop. Thymectomy (or splenectomy) before DSBT (not at transplantation) abrogate DSBT-Tregs generation and tolerance, showing that thymus (and spleen) are required for DSBT-Tregs generation (not for expansion/maintenance). In contrast with other Tregs models, DSBT-Tregs activity is not restricted to CD4+CD25+ but to CD4+CD45RC? cells, whereas CD4+CD45RC+ cells act as effector cells and accelerate rejection. In conclusion, DSBT alone induces—rapidly posttransplant—the development of alloantigen-specific Tregs in lymphoid tissues and in the graft. DSBT, graft, thymus, and spleen are required for DSBT-Tregs generation. DSBT-Tregs in this model are CD4+CD45RC? (identical to Tregs protecting from autoimmunity in rats).
机译:供体特异性输血(DSBT)促进器官同种异体移植接受的机制尚不清楚。在大鼠完全不匹配的心脏同种异体移植模型中,我们发现DSBT单独(未进行免疫治疗)可诱导移植后调节性T细胞(DSBT-Tregs)的发育,从而在输血作用机制上崭露头角。 DSBT-Tregs的间隔和时间,需求和表型尚不清楚。通常认为,Tregs发育需要一定的时间。但是,我们证明了-通过从DSBT的过继转移-可以耐受到幼稚的受体:1)移植后5天,脾脏和淋巴结中存在DSBT-Treg。 2)它们在这些隔室中逐渐膨胀; 3)移植后30天14在移植物中的存在。 DSBT-Treg是供体特异性的,不保护第三方同种异体移植物。来自DSBT治疗的非移植受体或未移植的DSBT(拒绝)受体的脾细胞不能转移耐受性,表明DSBT和移植物都需要足够数量的DSBT-Treg才能发育。 DSBT(不在移植时)前的胸腺切除术(或脾切除术)消除了DSBT-Tregs的产生和耐受性,表明DSBT-Tregs产生需要胸腺(和脾脏)(而不用于扩张/维持)。与其他Tregs模型相反,DSBT-Tregs活性不仅限于CD4 + CD25 +,而不仅限于CD4 + CD45RC?细胞,而CD4 + CD45RC +细胞充当效应细胞并加速排斥反应。总之,仅DSBT会(在移植后迅速)诱导淋巴组织和移植物中同种抗原特异性Treg的发展。 DSBT-Tregs产生需要DSBT,移植物,胸腺和脾脏。此模型中的DSBT-Treg是CD4 + CD45RC吗? (与保护大鼠免受自身免疫的Treg相同)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号